HeartSciences Inc. — Form SCHEDULE 13D/A
Filed October 23, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 22/100
What the filing says
This is an amended Schedule 13D/A filing for HeartSciences Inc. (market cap ~$10.4M), filed by Andrew Simpson on 2026-10-23. The document text provided does not contain the substantive amendment details—no specific share count changes, percentage of beneficial ownership, transaction amounts, or dates of material events are disclosed in the excerpt. To assess materiality, the actual Item 4-7 disclosures (which detail changes in holdings or control) are required but were not included in the filing text provided.
Why this rating
Schedule 13D/A amendments are routine regulatory filings. Without substantive disclosure of shareholding changes, transaction values, or control shifts relative to the $10.4M company size, this appears procedural. Significance escalates only if amendment reveals material ownership concentration or activist intent.
See more from October 23, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.